Additional Details
-
Better Breathers Club (Springfield, OR) | In-Person
Oregon Heart and Vascular Institute Conference Room 12C | 3311 River Bend DriveSpringfield OR. 97477 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteBay Saint Louis MS. 63110 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteUpland CA. 91786 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteMontreal H3T 1E2 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteNew York NY. 10029 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteGainesville FL. 32608 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteTrois RiviEres G9A 4P3 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteSalt Lake City UT. 84108 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteHouston TX. 77030 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteLos Angeles CA. 92868 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SitePotsdam NY. 13676 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SitePhiladelphia PA. 19140 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteTemple TX. 76508 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteNaples FL. 34102 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteSan Francisco CA. 94143 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteDurham NC. 27710 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteNew York NY. 10032 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteLos Angeles CA. 90033 -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteLos Angeles CA. 90095 -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
MD Anderson Cancer CenterHouston TX. 77030